Table 3.
Correlation coefficients between subjective quality of life and demographic/clinical variables
| Variables | SQLS-R4 psychosocial domain score | SQLS-R4 vitality domain score | SQLS-R4 total score |
|---|---|---|---|
| Age | −0.09 | 0.03 | −0.05 |
| Sex | −0.08 | −0.11 | −0.10 |
| Duration of illness | −0.10 | −0.02 | −0.08 |
| Number of relapse | −0.09 | 0.01 | −0.06 |
| Education | −0.08 | −0.01 | −0.05 |
| Marital status | −0.04 | −0.01 | −0.03 |
| Antipsychoticsa | −0.14 | −0.07 | −0.10 |
| Duration of current antipsychotic treatment | −0.05 | −0.02 | −0.04 |
| Use of concomitant medications | −0.07 | −0.09 | −0.08 |
| Manchester scale | |||
| Positive symptom score | 0.19 | 0.20 | 0.20 |
| Negative symptom score | 0.22 | 0.19 | 0.21 |
| Depression/anxiety symptom score | 0.43** | 0.36** | 0.42** |
| CDSS score | 0.58** | 0.50** | 0.58** |
Notes: Data are presented as Spearman’s rank correlation coefficients (ρ, two-tailed; for sex, marital status, antipsychotics, and the use of concomitant medications) and Pearson’s correlation coefficients (r, two-tailed; for the other variables).
a
The type of antipsychotics that patients were taking at the time of the assessment.
**
P<0.01.
Abbreviations: CDSS, Calgary Depression Scale for Schizophrenia; SQLS-R4, Schizophrenia Quality of Life Scale Revision 4.